Author(s):
Poovarasan. D, K. Manikandan, R. Kamaraj
Email(s):
poovarasan11355@gmail.com
DOI:
10.5958/0974-360X.2020.00277.2 
Address:
Poovarasan. D, K. Manikandan, R. Kamaraj
Department of Pharmaceutical Regulatory Affairs, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur-603203, Kanchipuram, Tamil Nadu, India.
*Corresponding Author
Published In:
Volume - 13,
Issue - 3,
Year - 2020
ABSTRACT:
Generic product is established by Pharmaceuticals and Medical Devices Agency to be approved for marketing in Japan respectively. Japan market is important to pharmaceutical industry. Japan is under one of the Regulated markets and owning the world’s second largest pharmaceutical market. Generic drugs are replaceable with original proprietary drugs, as they have the same active pharmaceutical ingredients, strength, quality, effects, dosage forms, indications, directions and dosage. The cost of generic product is lower than innovator product, because the developmental cost is low. The expansion of medical expenses is an important issue in many countries, including Japan, Europe and the USA and promotion of generic drugs has been demanded to solve this issue in Japan. An overview of checklist for requirements and registration process of generic product in Japan is provided.
Cite this article:
Poovarasan. D, K. Manikandan, R. Kamaraj. Regulatory Requirement and Registration Process of Generic Drugs in Japan. Research J. Pharm. and Tech 2020; 13(3):1523-1526. doi: 10.5958/0974-360X.2020.00277.2
Cite(Electronic):
Poovarasan. D, K. Manikandan, R. Kamaraj. Regulatory Requirement and Registration Process of Generic Drugs in Japan. Research J. Pharm. and Tech 2020; 13(3):1523-1526. doi: 10.5958/0974-360X.2020.00277.2 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2020-13-3-82
REFERENCES:
1. Japanese Regulatory Authority. Published in official website of PMDA Care [Internet] PMDA; [date unknown] [Cited on 2014 Dec 14]. Available from: http://www.pmda.go.jp/english/
2. JAPAN - An Attractive Market for Pharma. Published in Data monitor Health Care [Internet] Datamonitor Healthcare; 2014 Apr 23 [Cited on 2014 Dec 11].Available from: http://www.datamonitorhealthcare.com/japanese-pharma-market/
3. Services of PMDA [Internet] PMDA; [updated 2015 March; Cited on 2014 Dec 16]. Available from: http://www.pmda.go.jp/english/service/index.html
4. Introduction to Generic Drug. Published in WHO [Internet]. WHO; 2015 [cited 2014 Dec10]. Available from: http://www.who.int/trade/glossary/story034/en/
5. Introduction to regulatory affairs. Published in Regulatory Affairs Professional Society (RAPS) [Internet]. RAPS; 2013 [cited 2014 Dec11]. Available from:
6. http://www.raps.org/uploadedFiles/Site_Setup/Home_Page/About_RAPS/The_Regulatory_Profession/PDF_Framework_Whitepaper.pdf
7. Davidson A. Pharmaceutical Markets. Global Regulatory Development, PPD [Internet].TOPRA [date unknown] [cited 2014 Dec10]. Available from:
8. https://www.topra.org/sites/default/files/assets/reg._strategy_for_the_emerging_markets__a.davidson.pdf
9. Comparison of Innovator and Generic Drugs [Internet]. Canadian Agency for Drugs and Technologies in Health; 2015 [cited 2014 Dec12]. Available from:
10. http://www.cadth.ca/en/resources/generics/your-questions-answered
11. Montu PB, Songara R. Design and development of common Generic product development strategy. Asian journal of pharmaceutical science and research[Internet] 2011 June [Cited on 2014 Dec 25]; 1(1):10-19 Available from: http://www.ordonearresearchlibrary.com/data/pdfs/ajpsr2.pdf
12. Stages involved in Generic Drug Development. Generic drug Development Published by Dr.Venkateswarlu Head of FR&D Dr.Reddys laboratories.[Internet].Author stream; 2014 [cited 2014 Dec14]. Available from: http://www.authorstream.com/Presentation/ravikumarpharma-1090595-generic-product-development-by-dr-venkateswarlu/
13. Requirements for Registration of Generic Drugs in Japan [Internet] CFDA [updated 2015 Feb; Cited on 2014 Dec 15]. Available from: http://eng.sfda.gov.cn/WS03/CL0755/
14. Bhardwaj S. et al. Comparative study: requirements for the submission of Generic drug application across US and EU in CTD/eCTD format. AJPSR.[Internet] 2011 [Cited on 2014 Dec 15]; 1(5):1-14.
15. Available from:http://www.ordonearresearchlibrary.com/Data/pdfs/AJPSR22.pdf